(Q34127280)

31 July 2017

Sphingosine 1-phosphate receptor 1 and 3 are upregulated in multiple sclerosis lesions (English)

1 reference

31 July 2017

0 references

2

Jack Van Horssen

1 reference

31 July 2017

13

Helga E De Vries

1 reference

31 July 2017

Ruben Van Doorn

1

1 reference

31 July 2017

Dennis Verzijl

3

1 reference

31 July 2017

Maarten Witte

4

1 reference

31 July 2017

Eric Ronken

5

1 reference

31 July 2017

Bert Van Het Hof

6

1 reference

31 July 2017

Kim Lakeman

7

1 reference

31 July 2017

Christine D Dijkstra

8

1 reference

31 July 2017

Paul Van Der Valk

9

1 reference

31 July 2017

Arie Reijerkerk

10

1 reference

31 July 2017

Astrid E Alewijnse

11

1 reference

31 July 2017

Stephan L M Peters

12

1 reference

31 July 2017

1 September 2010

1 reference

31 July 2017

1 reference

31 July 2017

58

1 reference

31 July 2017

12

1 reference

31 July 2017

1465-1476

1 reference

Astrocyte-endothelial interactions and blood-brain barrier permeability

31 July 2017

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21021

7 January 2021

Cell surface receptors in lysophospholipid signaling

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21021

7 January 2021

The immune modulator FTY720 targets sphingosine 1-phosphate receptors

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21021

7 January 2021

Sphingosine 1-phosphate and ceramide 1-phosphate: expanding roles in cell signaling

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21021

7 January 2021

Establishment of human adult astrocyte cultures derived from postmortem multiple sclerosis and control brain and spinal cord regions: immunophenotypical and functional characterization.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21021

7 January 2021

The glial scar and central nervous system repair

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21021

7 January 2021

Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: consequences for mode of action in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21021

7 January 2021

The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G-protein-coupled receptors

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21021

7 January 2021

Erythrocytes store and release sphingosine 1-phosphate in blood.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21021

7 January 2021

Production and function of monocyte chemoattractant protein-1 and other beta-chemokines in murine glial cells

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21021

7 January 2021

Analysis of endogenous S1P and LPA receptor expression in CHO-K1 cells

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21021

7 January 2021

Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21021

7 January 2021

Validation of a rapid, non-radioactive method to quantify internalisation of G-protein coupled receptors

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21021

7 January 2021

BML-241 fails to display selective antagonism at the sphingosine-1-phosphate receptor, S1P(3).

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21021

7 January 2021

Oral fingolimod (FTY720) for relapsing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21021

7 January 2021

Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21021

7 January 2021

FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21021

7 January 2021

Cyclical and dose-dependent responses of adult human mature oligodendrocytes to fingolimod.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21021

7 January 2021

FTY720 modulates human oligodendrocyte progenitor process extension and survival.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21021

7 January 2021

Phosphorylated FTY720 promotes astrocyte migration through sphingosine-1-phosphate receptors.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21021

7 January 2021

Persistent signaling induced by FTY720-phosphate is mediated by internalized S1P1 receptors.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21021

7 January 2021

Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21021

7 January 2021

Phosphorylated FTY720 stimulates ERK phosphorylation in astrocytes via S1P receptors.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21021

7 January 2021

Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21021

7 January 2021

Structural and functional characteristics of S1P receptors.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21021

7 January 2021

Expression of monocyte chemoattractant protein-1 and other beta-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21021

7 January 2021

Protein kinase Calpha-RhoA cross-talk in CCL2-induced alterations in brain endothelial permeability

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21021

7 January 2021

Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21021

7 January 2021

NAD(P)H:quinone oxidoreductase 1 expression in multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21021

7 January 2021

Severe oxidative damage in multiple sclerosis lesions coincides with enhanced antioxidant enzyme expression.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21021

7 January 2021

Distinctive G protein-dependent signaling in smooth muscle by sphingosine 1-phosphate receptors S1P1 and S1P2.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21021

7 January 2021

Identifiers

DOI

10.1002/GLIA.21021

1 reference

31 July 2017

1 reference